Hemoglobin E levels in double heterozygotes of hemoglobin E and sea-type α-thalassemia
Coinheritance of α-thalassemia and hemoglobin E (Hb E) is prevalent in Thailand, where the gene frequencies of thalassemia and hemoglobinopathies are high. Hb E carriers with, concomitant inheritance of α-thalassemia 1 are known to have a lower level of Hb E. In this study, we reviewed the Hb E leve...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-20444444692&partnerID=40&md5=e01f8ea2cb8f66d1487b8fc23052d5f3 http://cmuir.cmu.ac.th/handle/6653943832/1945 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Summary: | Coinheritance of α-thalassemia and hemoglobin E (Hb E) is prevalent in Thailand, where the gene frequencies of thalassemia and hemoglobinopathies are high. Hb E carriers with, concomitant inheritance of α-thalassemia 1 are known to have a lower level of Hb E. In this study, we reviewed the Hb E levels in Hb E carriers, who either had or did not have Southeast Asian (SEA)-type α-thalassemia, in order to seek a Hb E level that may be used as a predictor for concomitant α-thalassemia carrier status. The Hb E levels as measured by microcolumn chromatography in 844 Hb E carriers detected during a prenatal screening program for severe thalassemia at Chiang Mai University Hospital were reviewed. Hb E levels ranged from 12.3-35.0% (23.3±3.1%) in 751 Hb E carriers without SEA-type α-thalassemia and from 11.6-32.0% (17.0±3.7%) in 93 concomitant Hb E and SEA-type α-thalassemia carriers. The difference was significant (p<0.01). However, the absence of SEA-type α-thalassemia could not be predicted by the higher Hb E level alone, as 3% of double heterozygotes demonstrated a level of more than 25%. Our study confirms a lower Hb E level in double heterozygotes with Hb E and SEA-type α-thalassemia. Nevertheless, the difference does not provide sufficient discriminatory power for the reliable exclusion of α-thalassemia status. |
---|